Triley Bidco Limited acquires Clinigen Group plc

The board of directors of Clinigen Group plc and the board of directors of Triley Bidco Limited Jan. 17 agreed the terms of an increased and final recommended all-cash offer for Clinigen by Bidco, a newly-incorporated company indirectly owned by the Triton Funds, pursuant to which Bidco will acquire the entire issued and to be issued ordinary share capital of Clinigen at a price of 925 pence in cash per Clinigen share

You need to subscribe for access to restricted content.

Sign up
Forgot your password?